Tech Leverage Woes: $10,000 FNGU Becomes $8,392 in One Session
A single-session drop in the 3X leveraged FNGU ETN trimmed a $10,000 bet to $8,392, illustrating how tech leverage ca...
Articles — Page 879
Drilling Rises Longest U.S. Run Since 2022 as Prices Jump
U.S. oil drillers added two rigs to 431, marking six straight weeks of growth—the longest run since mid-2022. Prices ...
Trump Says Supports Salary Cap Shakeup in MLB Talks
A growing clash over baseball economics enters a new phase as Trump signals support for a hard salary cap in MLB, int...
Former Czar Calls Sanders’ Plan a Tax, Warns on AI Stakes
A high-profile former AI czar challenges Sanders’ 50% government stake plan for AI firms, warning that nationalizatio...
During D-Day Speech France, Immigration Debate Moves Markets
On the 82nd anniversary of D-Day, a French ceremony framed migration as a security issue, triggering mixed market sig...
SpaceX and Other Mega IPOs May Wait Years for S&P 500
SpaceX and other mega IPOs are unlikely to join the S&P 500 any time soon as profitability requirements remain in pla...
Housing Demand Stays Positive as Rates Near 2026 Highs
Despite rates at year-to-year highs, housing demand stays positive as weekly data on pending sales and mortgage appli...
NVIDIA Just Slipped Below: Who Could Catch It Next
NVIDIA just slipped below a historic milestone, reigniting the debate about who could realistically challenge its AI ...
Motorola's $1.5 Billion D-Fend: A Bold Move in Public Safety Tech
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
Should Investors Sell Tesla to Buy SpaceX? A Practical Guide
Investors often ask if selling Tesla to invest in SpaceX could pay off. This guide breaks down the reality, the optio...
Beaten-Down GitLab Stock Revenue: Is GTLB a Buy?
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...